October Science Corner
October 8, 2019 On September 23, 2019, the Food and Drug Administration (FDA) issued its most recent guidance document for the development of potential treatments for ALS. Many representatives of the ALS community – patient advocates like our friends Phil Green and Matt Bellina, researchers, organizations like Augie’s Quest, ALS TDI, Team Gleason and IamALS – gathered in Washington to collaborate with government officials to help fast-track the funding, clinical research design, and focus needed to uncover effective treatments and an ultimate cure for this disease.
Read More >